Cargando…
SARS-CoV-2 omicron BA.1.1 is highly resistant to antibody neutralization of convalescent serum from the origin strain
The emergence and rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant (BA.1.1) has attracted global attention. The numerous mutations in the spike protein suggest that it may have altered susceptibility to immune protection elicited by the existing corona...
Autores principales: | Li, Jianhua, Li, Xiaoyan, Mao, Haiyan, Huang, Chen, Sun, Yi, Miao, Liangbin, Li, Jiaxuan, Song, Wanchen, Zhang, Yanjun, Huang, Jinsong, Chen, Keda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200063/ https://www.ncbi.nlm.nih.gov/pubmed/37178794 http://dx.doi.org/10.1016/j.virusres.2023.199131 |
Ejemplares similares
-
Neutralizing Antibodies against the SARS-CoV-2 Delta and Omicron BA.1 following Homologous CoronaVac Booster Vaccination
por: Li, Jianhua, et al.
Publicado: (2022) -
The role of SARS-CoV-2 N protein in diagnosis and vaccination in the context of emerging variants: present status and prospects
por: Song, Wanchen, et al.
Publicado: (2023) -
Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5
por: Diem, Gabriel, et al.
Publicado: (2023) -
Omicron BA.5 Neutralization among Vaccine-Boosted Persons with Prior Omicron BA.1/BA.2 Infections
por: Pedersen, Rune M., et al.
Publicado: (2022) -
Immunity of Heterologously and Homologously Boosted or Convalescent Individuals Against Omicron BA.1, BA.2, and BA.4/5 Variants
por: Jäger, Michael, et al.
Publicado: (2023)